Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Size & Outlook
The diabetes associated ophthalmic treatment market in Saudi Arabia is expected to reach a projected revenue of US$ 540.0 million by 2028. A compound annual growth rate of 4.6% is expected of Saudi Arabia diabetes associated ophthalmic treatment market from 2021 to 2028.
Revenue, 2020 (US$M)
$378.1
Forecast, 2028 (US$M)
$540.0
CAGR, 2021 - 2028
4.6%
Report Coverage
Saudi Arabia
Saudi Arabia diabetes associated ophthalmic treatment market, 2017-2028 (US$M)
Related Markets
Saudi Arabia diabetes associated ophthalmic treatment market highlights
- The Saudi Arabia diabetes associated ophthalmic treatment market generated a revenue of USD 378.1 million in 2020 and is expected to reach USD 540.0 million by 2028.
- The Saudi Arabia market is expected to grow at a CAGR of 4.6% from 2021 to 2028.
- In terms of segment, diabetic retinopathy was the largest revenue generating application in 2020.
- Uveitis is the most lucrative application segment registering the fastest growth during the forecast period.
Diabetes associated ophthalmic treatment market data book summary
| Market revenue in 2020 | USD 378.1 million |
| Market revenue in 2028 | USD 540.0 million |
| Growth rate | 4.6% (CAGR from 2020 to 2028) |
| Largest segment | Diabetic retinopathy |
| Fastest growing segment | Uveitis |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic-associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema, Other Application |
| Key market players worldwide | Alcon Inc, Johnson & Johnson, Bausch Health Companies Inc, Roche, Allergan, Bayer AG, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Pfizer Inc, Genentech, Carl Zeiss Meditec AG, Lumenis, Ellex, IRIDEX Corp, Topcon Corp, Abbott Laboratories, Quantel |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.4% of the global diabetes associated ophthalmic treatment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Middle East & Africa, South Africa diabetes associated ophthalmic treatment market is projected to lead the regional market in terms of revenue in 2028.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 540.0 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Associated Ophthalmic Treatment Market Scope
Diabetes associated ophthalmic treatment market segmentation & scope
Diabetes Associated Ophthalmic Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia diabetes associated ophthalmic treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes associated ophthalmic treatment market will help companies and investors design strategic landscapes.
Diabetic retinopathy was the largest segment with a revenue share of 25.92% in 2020. Horizon Databook has segmented the Saudi Arabia diabetes associated ophthalmic treatment market based on dry eye syndrome, glaucoma, eye allergy & infection, diabetic retinopathy, diabetic-associated macular degeneration, uveitis, cataract, diabetic macular edema, other application covering the revenue growth of each sub-segment from 2017 to 2028.
- Saudi Arabia Diabetes Associated Ophthalmic Treatment Application Outlook (Revenue, USD Million, 2017-2028)
- Dry Eye Syndrome
- Glaucoma
- Eye Allergy & Infection
- Diabetic Retinopathy
- Diabetic-associated Macular Degeneration
- Uveitis
- Cataract
- Diabetic Macular Edema
- Other Application
- Saudi Arabia Diabetes Associated Ophthalmic Treatment Type Outlook (Revenue, USD Million, 2017-2028)
- Drugs
- Devices
- Saudi Arabia Diabetes Associated Ophthalmic Treatment End Use Outlook (Revenue, USD Million, 2017-2028)
- Hospitals
- Ophthalmic Centers
- Ambulatory Centers
- Others End Use
Reasons to subscribe to Saudi Arabia diabetes associated ophthalmic treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia diabetes associated ophthalmic treatment market databook
-
Our clientele includes a mix of diabetes associated ophthalmic treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia diabetes associated ophthalmic treatment market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia diabetes associated ophthalmic treatment market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia diabetes associated ophthalmic treatment market size, by application, 2017-2028 (US$M)
Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
